Anti-CD44v10 Antibody, exon v10

Epitope: exon v10

Synthetic peptide of human CD44v10

ELISA: 1:2000
Flow Cytometry: 1:1000
Immunofluorescence: 1:200
Immunohistostaining of paraffin embedded tissue: 1:250
Immunoprecipitation: 1:200
Western Blotting: 1:1000
RIA: 1:5000

Optimal working dilutions must be determined by the end user.

This Anti-CD44v10 Antibody, exon v10 is validated for use in ELISA, FC, IP, RIA, WB, IC, IH(P) for the detection of CD44v10.

CD44v10 Approximant 116 kDa)

Recent studies indicate that the expression of CD44 on the cell surface changes profoundly during tumor metastasis, particularly during the progression of various carcinomas. Sequencing analysis reveals that CD44 exists in different forms (at least 15 isoforms have been identified) that are variants of the common or standard hemopoietic form CD44s. Specifically, the human CD44 gene contains 19 exons, out of which 10 exons can potentially be alternatively spliced. In particular, CD44s contains exons 1-15 and exons 15-19. The other exons (e.g. 6-14) are also spliced in a variety of different cells. For example, epithelial cells contain exons 12-14 inserted into the CD44s transcripts. This isoform has been designated as CD44E. Other CD44 variants CD44v) have the same sequences at the two ends of the molecule, but differ in a middle region (with different numbers of additional exons) located on the external side of the cell membrane. It has been suggested that expression of CD44 variants with the additional exon 14 (so-called v10) is responsible for tumor progression and metastasis. In fact, CD44v10 expression has been used as an indicator of metastasis.

Format: Purified

Purified immunoglobulin. Liquid in 10 mM sodium phosphate, 150 mM NaCl with 0.01% sodium azide.

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Replaces: 04-1123

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany